Campath, calcineurin inhibitor reduction, and chronic allograft nephropathy (the 3C Study) - results of a randomized controlled clinical trial. (2018)

First Author: 3C Study Collaborative Group

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/ajt.14619

PubMed Identifier: 29226570

Publication URI: http://europepmc.org/abstract/MED/29226570

Type: Journal Article/Review

Volume: 18

Parent Publication: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Issue: 6

ISSN: 1600-6135